Most Favored Nation: Global Benchmarking to Reimagine US Drug Distribution
Dec 18, 02:15 PM
Share
Subscribe
Ron Lanton III, Esq, joined Over the Counter to discuss the Most Favored Nation drug pricing policy and what exactly it may mean for stakeholders heading into 2026.